Today: 17 May 2026
Telstra share price dips as ASX slides — RBA hike odds and March dividend in focus
4 March 2026
2 mins read

Telstra share price dips as ASX slides — RBA hike odds and March dividend in focus

Sydney, March 4, 2026, 17:41 (AEDT) — Market closed.

  • Telstra (TLS.AX) closed at A$5.16, slipping roughly 1%. The stock’s loss was less pronounced than what played out across the wider market.
  • ASX 200 slumped 1.94%, with traders shaken by Middle East tensions and renewed rate-hike chatter denting risk appetite.
  • Telstra’s dividend reinvestment pricing window stays open until March 6. Cash dividend lands March 27.

Shares of Telstra Group Limited fell Wednesday, with the broader Australian market under pressure and investors eyeing the threat of rising interest rates.

The stock’s reputation as a “bond proxy”—solid dividends, but less appealing when yields tick up—comes into focus this week. With the Reserve Bank of Australia sounding more hawkish, traders are now weighing up the odds of a rate hike as early as March.

Telstra’s interim dividend lands on the schedule, with shareholders set for a A$0.105 per share payment slated for March 27. This week, the company is locking in the price for its dividend reinvestment plan (DRP)—the program allowing investors to take shares rather than cash. According to Telstra, the DRP price will reflect the average daily volume-weighted price (VWAP) between March 2 and March 6, no discount attached.

Telstra ended the session at A$5.16, slipping 5 cents from Tuesday. Shares moved in a narrow range—A$5.15 to A$5.22. Turnover landed at just 6.7 million, a steep drop from the 19 to 24 million shares recorded in each of the last two days, StockAnalysis data shows.

The S&P/ASX 200 dropped 1.94% to close at 8,901.20, following a 1.34% decline the previous session, according to Investing.com data.

Macro worries took center stage. Australia posted 0.8% GDP growth for the December quarter, with annual expansion at 2.6%. That pace has stoked inflation worries, especially as oil surged on Middle East tensions, Reuters said. “Combined with elevated inflation, today’s data will keep the RBA on high alert and increase the likelihood of a rate hike in May,” Deloitte Access Economics partner Stephen Smith told Reuters. Reuters

Just a day before, RBA Governor Michele Bullock sent a clear signal to markets: don’t count on the central bank holding off until the next quarterly inflation print before acting. “I’m not making a prediction about March but it will be a live meeting,” Bullock told attendees at a business summit, noting the board would be “actively looking” at the case for moving sooner. Traders adjusted quickly, with implied odds rising to roughly 30% for a March rate hike and expectations for a full move by May, according to Reuters. Reuters

For Telstra, it’s an awkward look, given the company has relied on capital returns to keep shareholders interested. After reporting its first-half numbers in February, Telstra bumped up its interim dividend to 10.5 Australian cents and expanded its on-market buyback to as much as A$1.25 billion—moves backed by a jump in customer numbers and pricier mobile plans, according to Reuters.

The next move, though, hinges less on Telstra itself and more on what’s happening across the board. Should bond yields push higher, or if the RBA surprises with an early rate hike, high-yield defensives like this could feel the squeeze—buybacks or not.

Next up for investors: the DRP pricing window wraps on March 6, with the interim dividend set for March 27. After that, eyes turn to the RBA’s March 16–17 meeting, then the quarterly CPI numbers scheduled for April 29.

Stock Market Today

  • Monster Beverage (MNST) Stock Near Fair Value After Multi-Year Gains
    May 16, 2026, 9:18 PM EDT. Monster Beverage (MNST) has delivered strong returns, rising nearly 89% over five years. The stock recently traded at around $87, modestly above its estimated intrinsic value of $80.02 based on a Discounted Cash Flow (DCF) model. This valuation approach projects Monster's free cash flow growing from $1.94 billion to over $3 billion by 2030. Despite impressive share price gains, the DCF suggests Monster is roughly 8.8% overvalued, indicating current prices are close to fair value rather than significantly overpriced. While the company's position in the US energy drink market supports growth prospects, its valuation score was 0 out of 6 on standard metrics, urging caution for new investors. Traders should monitor valuation shifts and market developments to time entries appropriately.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

Stock Market Today 04.03.2026

Snowflake edges closer to the sales floor as EY and Canva roll out “agentic” AI platform
Next Story

Snowflake edges closer to the sales floor as EY and Canva roll out “agentic” AI platform

Go toTop